Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cardiology
Pharmaceutical company announces results of heart disease risk study
December 6th, 2004
LipoScience announced the results of a major study confirming that the number of LDL particles (LDL-P) measured by nuclear magnetic resonance (NMR) spectroscopy provides better prediction of heart disease risk than levels of LDL cholesterol (LDL-C). In a paper presented at the recent American Heart Association meeting, LDL-P was shown to provide significantly more information about cardiovascular risk in middle-aged men and women followed prospectively over eight years than traditional cholesterol measures. The risk associated with elevated LDL-P was independent not only of LDL and HDL cholesterol, but also of non-lipid risk factors such as age, high blood pressure,...
Source: Obesity & Diabetes Week (2004-12-06)
|
